Source: European Journal of Pharmacology. Unidades: FMRP, FCFRP, FORP
Subjects: DIABETES MELLITUS, METALOPROTEINASES, DOENÇAS CARDIOVASCULARES, ESTRESSE OXIDATIVO
ABNT
MARTINEZ, Marcio L. L. et al. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, v. 599, n. 1-3, p. 110-116, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.10.007. Acesso em: 17 out. 2024.APA
Martinez, M. L. L., Rizzi, E., Castro, M. M., Fernandes, K., Bendhack, L. M., Gerlach, R. F., & Tanus-Santos, J. E. (2008). Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, 599( 1-3), 110-116. doi:10.1016/j.ejphar.2008.10.007NLM
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007Vancouver
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007